Skip to Main Content

Paper Details

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.
Leukemia
6
2021
Author NameAffiliation
Matthieu DuchmannAssistance Publique-Hopitaux de Paris, University of Paris
Matthieu DuchmannUniversite de Paris, INSERM, CNRS
Emmanuel RaffouxAssistance Publique-Hopitaux de Paris
Anna RaimbaultAssistance Publique-Hopitaux de Paris, University of Paris
Lionel Ad??sUniversite de Paris, INSERM, CNRS
Lionel Ad??sAssistance Publique-Hopitaux de Paris, University of Paris
Jean SoulierAssistance Publique-Hopitaux de Paris, University of Paris
Jean SoulierUniversite de Paris, INSERM, CNRS
Herv?? DombretAssistance Publique-Hopitaux de Paris
Herv?? DombretSaint-Louis Resarch Institute, University of Paris
Emmanuelle ClappierAssistance Publique-Hopitaux de Paris, University of Paris
Emmanuelle ClappierUniversite de Paris, INSERM, CNRS
Raphael ItzyksonAssistance Publique-Hopitaux de Paris
Raphael ItzyksonUniversite de Paris, INSERM, CNRS
  • 1 - 14

Datasets